Schedules under the Drugs and Cosmetics Act Notes [U-2]
Get The High-Quality Pdf Notes on App
Detailed Study of Schedules G, H, M, N, P, T, U, V, X, Y, Part XII B, Schedule F & DMR (OA)
- Detailed Study of Schedules
Sale of Drugs
- Wholesale Sale of Drugs
- Retail Sale of Drugs
- Restricted License
- Offences and Penalties
Labeling & Packing of Drugs
- General Labeling Requirements
- Specimen Labels for Drugs and Cosmetics
- List of Permitted Colors
- Offences and Penalties Related to Labeling & Packing
Administration of the Act and Rules
- Drugs Technical Advisory Board (DTAB)
- Central Drugs Laboratory (CDL)
- Drugs Consultative Committee (DCC)
- Government Drug Analysts (GDAs)
- Licensing Authorities
- Controlling Authorities
- Drugs Inspectors
Summary of Unit II: Drugs and Cosmetics Act, 1940 and Rules, 1945
Unit II provides an in-depth understanding of key Schedules under the Drugs and Cosmetics Act, including Schedules G, H, M, N, P, T, U, V, X, Y, Part XII B, Sch F, and DMR (OA). These schedules govern the classification, manufacturing, and control standards for various drug types and medical practices.
The unit elaborates on drug sales, including:
- Wholesale, retail, and restricted licenses
- Associated offences and penalties for violations
A comprehensive section covers labeling and packing regulations, including:
- General labeling rules and specimen labels
- Permitted color list for drugs and cosmetics
- Penalties for non-compliance
It also highlights the administrative framework supporting the Act, including:
- Drugs Technical Advisory Board (DTAB)
- Central Drugs Laboratory, Drugs Consultative Committee
- Roles of Government drug analysts, licensing & controlling authorities, and Drugs Inspectors
